RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Effective tax rate (%)

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndEffective tax rate (%) (Million USD)YoY (%)
Dec 31, 202415.6-15.83%
Dec 31, 202318.6-8.18%
Dec 31, 202220.2-17.48%
Dec 31, 202124.5-67.88%
Dec 31, 202076.3+235.05%
Dec 31, 201922.8-30.75%
Dec 31, 201832.9-118.51%
Dec 31, 2017-177.8-701.89%
Dec 31, 201629.5-59.60%
Dec 31, 201573.1+78.12%
Dec 31, 201441

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)